Sedivention is a medtech startup that develops medical technology for minimally invasive obesity treatment through cryo-ablation procedures.
Sedivention has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Sedivention's investors include IBG funds, HTGF (High-Tech Gruenderfonds), bmp Ventures, Super Angels, Cambridge Ventures.
Sedivention is headquartered in Munich, Germany.
Sedivention is a medtech startup that develops medical technology for minimally invasive obesity treatment through cryo-ablation procedures.
Sedivention is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sedivention — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/sedivention. Accessed July 19, 2026.
VCBacked. (2026). Sedivention — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sedivention
{{cite web |title=Sedivention — Funding & Investors |url=https://www.vcbacked.co/company/sedivention |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated